Dysregulation of the inflammatory response system has been linked to pathop
hysiology of schizophrenia.(1,2) Evidence of immune activation has derived
from the detection of abnormal levels of proinflammatory cytokines and thei
r receptors in peripheral blood and cerebrospinal fluid from schizophrenic
patients.(3-7) Cytokines are involved in normal CNS development as well as
in the pathogenesis of many neuro-psychiatric disorders, acting directly on
neural cells or modulating neurotransmitter and neuropeptide systems.(8,9)
In particular tumor necrosis factor alpha (TNF alpha), depending on its co
ncentration, can exert both neurotrophic and neurotoxic effects and influen
ce neural cell growth and proliferation.(10,11) Moreover, TNF alpha gene is
located on the small arm of chromosome 6 (6p21.1-21.3), a locus associated
with genetic susceptibility to schizophrenia.(12,13) We studied the distri
bution of -G308A TNF alpha gene polymorphism in 84 schizophrenic patients a
nd in 138 healthy volunteers. This biallelic base exchange polymorphism dir
ectly affects TNF alpha plasma levels.(14-18) Frequency of the TNF2(A) alle
le is significantly increased in schizophrenic patients as compared to cont
rols (P = 0.0042). Genotype distribution is also significantly different (P
= 0.0024). TNF2 homozygotes are represented only in the patient group (P =
0.002). These data suggest a potential role of TNF alpha as a candidate ge
ne for susceptibility to schizophrenia and suggest that immune dysregulatio
n in schizophrenic patients could also have a genetic component.